Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to fall 64.18% to -23 cents per share on May 08
Q1'25
Est.
$-0.24
Q4'24
Missed
by $0.27
Q3'24
Missed
by $0.28
Q2'24
Missed
by $0.02
Q1'24
Beat
by $0.07
The last earnings report on March 11 showed earnings per share of -67 cents, missing the estimate of -40 cents. With 452.57K shares outstanding, the current market capitalization sits at 401.54M.